Effect of noradrenalin and EGb 761 pretreatment on the ischemia-reperfusion injured spinal cord neurons in rabbits.
Short term sublethal ischemia or ischemic preconditioning gives protection to the neurons against subsequent lethal ischemic attack. This so-called ischemic tolerance can also be provided by certain drugs. We examined the effect of noradrenalin and EGb 761 on the spinal cord neurons injured by 30 min occlusion of abdominal aorta in rabbits. The animals survived 48 and 72 h. Degenerated neurons were visualized by Fluoro Jade B method, viable neurons were demonstrated immunohistochemically with NeuN and ubiquitin antibodies. The rabbits with noradrenalin administration 48 h before 30 min of ischemia and 48/72 h of reperfusion, showed significant increase of degenerated Fluoro Jade B labeled neurons. Animals of both groups were paraplegic. Rabbits pretreated 7 days with EGb 761 prior to 30 min of ischemia and with 48/72 h of reperfusion revealed significant decrease of Fluoro Jade B-positive neurons when compared with the groups with 30 min of ischemia followed by 48/72 h of reperfusion. In the NeuN sections, the number of viable neurons was moderately decreased. These animals showed no paraplegia. Ubiquitin aggregates occurred in the cytoplasm of degenerated neurons in the sections of rabbits preconditioned with noradrenalin 48 h prior to 30 min of ischemia and followed by 48 h of reperfusion while after 72 h of reperfusion, shrunk light shadows without ubiquitin reaction were visible. Our results indicate that EGb 761 could be involved in protection of spinal cord neurons against ischemic injury while effect of noradrenalin is not unambiguous.
Mechírová
Eva
E
Department of Histology and Embryology, Faculty of Medicine, PJ Safárik University in Kosice, 04180 Kosice, Slovak Republic. mechir@post.sk
Domoráková
Iveta
I
Danková
Marianna
M
Danielisová
Viera
V
Burda
Jozef
J
D000818:Animals; D002452:Cell Count; D005452:Fluoresceins; D020441:Ginkgo biloba; D007150:Immunohistochemistry; D007511:Ischemia / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009474:Neurons / Q000473:pathology; D009638:Norepinephrine / Q000627:therapeutic use*; D009930:Organic Chemicals; D010936:Plant Extracts / Q000627:therapeutic use*; D011817:Rabbits; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000473:pathology; D013116:Spinal Cord / Q000098:blood supply / Q000473:pathology; D000096983:Ginkgo Extract
D005452:Fluoresceins; D009638:Norepinephrine; D009930:Organic Chemicals; D010936:Plant Extracts; C435731:fluoro jade; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract